From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors

  • Adv Exp Med Biol. 1997:407:73-8.
C K Lau  1 ,  W C Black ,  M Belley ,  C Chan ,  S Charleson ,  D Denis ,  J Y Gauthier ,  R Gordon ,  D Guay ,  P Hamel ,  S Kargman ,  Y Leblanc ,  J Mancini ,  M Ouellet ,  D Percival ,  P Prasit ,  P Roy ,  K Skorey ,  P Tagari ,  P Vickers ,  E Wong
Affiliations
  • 1. Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Québec, Canada.
PMID: 9321934
Products